Shows superior glucose tolerance preservation in patients with low-grade malignancies, suggesting a valuable surgical option.
Despite higher morbidity, MP demonstrated superior preservation of long-term glucose tolerance compared with DP. These findings suggest that MP is a valuable parenchyma-preserving option for patients with low-grade malignant pancreatic tumors, particularly those at increased risk of postoperative DM, although careful consideration of surgical risks is required.
No takes yet. Share an insight, caveat, or question.
Fujinaga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: